Winnipeg Free Press By: Mia Rabson, The Canadian Press Posted:
Last Modified: 2:14 PM CDT Thursday, May. 13, 2021 Save to Read Later
OTTAWA - A homegrown mRNA vaccine for COVID-19 shows promising results in its first small trial and its maker is hoping to test it directly against the vaccine from Pfizer-BioNTech.
People are vaccinated at the Palais de Congress COVID-19 vaccination clinic, Thursday, May 13, 2021 in Montreal.THE CANADIAN PRESS/Ryan Remiorz
OTTAWA - A homegrown mRNA vaccine for COVID-19 shows promising results in its first small trial and its maker is hoping to test it directly against the vaccine from Pfizer-BioNTech.
Canadian maker of promising mRNA vaccine looks to test it against Pfizer in new trial - Canada News castanet.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from castanet.net Daily Mail and Mail on Sunday newspapers.
Mia Rabson
People are vaccinated at the Palais de Congress COVID-19 vaccination clinic, Thursday, May 13, 2021 in Montreal.THE CANADIAN PRESS/Ryan Remiorz May 13, 2021 - 2:21 PM
OTTAWA - A homegrown mRNA vaccine for COVID-19 shows promising results in its first small trial and its maker is hoping to test it directly against the vaccine from Pfizer-BioNTech.
Calgary-based Providence Therapeutics says its vaccine produced no serious adverse events and developed good antibodies against COVID-19 that compare favourably with the two mRNA vaccines already on the market from Pfizer and Moderna. We re extremely pleased, said Providence CEO Brad Sorenson.
The Phase 1 trial included 60 healthy adults between 18 and 64, with more than half of them receiving two doses of the vaccine, four weeks apart. The results have not yet been peer-reviewed.
iPolitics AM: Trudeau faces House on what s supposed to be Line 5 s last day ipolitics.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ipolitics.ca Daily Mail and Mail on Sunday newspapers.